Verition Fund Management LLC Ovid Therapeutics Inc. Transaction History
Verition Fund Management LLC
- $19.9 Billion
- Q1 2025
A detailed history of Verition Fund Management LLC transactions in Ovid Therapeutics Inc. stock. As of the latest transaction made, Verition Fund Management LLC holds 215,060 shares of OVID stock, worth $66,668. This represents 0.0% of its overall portfolio holdings.
Number of Shares
215,060
Previous 147,305
46.0%
Holding current value
$66,668
Previous $136,000
51.47%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding OVID
# of Institutions
83Shares Held
39.5MCall Options Held
1.7KPut Options Held
100-
Rubric Capital Management LP New York, NY5.32MShares$1.65 Million0.05% of portfolio
-
Black Rock Inc. New York, NY3.99MShares$1.24 Million0.0% of portfolio
-
Bvf Inc San Francisco, CA3.85MShares$1.19 Million0.05% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.11MShares$963,7220.0% of portfolio
-
Madison Avenue Partners, LP New York, NY2.47MShares$764,3430.1% of portfolio
About Ovid Therapeutics Inc.
- Ticker OVID
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 70,419,400
- Market Cap $21.8M
- Description
- Ovid Therapeutics Inc., a biopharmaceutical company, develops impactful medicines for patients and families with neurological disorders in the United States. The company is developing OV101, a drug candidate, which is in Phase 2A clinical trials for the treatment of fragile X syndrome; OV329, a GABA aminotransferase inhibitor for the treatment o...